A Pharmacokinetics and Safety Study of Nemolizumab in Adolescent Subjects With Atopic Dermatitis (AD)
Condition: Atopic Dermatitis Intervention: Biological: Nemolizumab Sponsor: Galderma R&D Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials